Genekam Biotechnology AG
Influenza, Coronavirus, SARS, B cells, human monoclonal antibodies, Genetherapy, magnetic beads, PCR, vaccine, therapy
Influenza, Coronavirus, SARS, B cells, human monoclonal antibodies, Genetherapy, magnetic beads, PCR, vaccine, therapy
Genekam Biotechnology AG has around 700 products like ready To use PCR kits for different targets like, Ebola, HIV, CMV, Influenza viruses, genetherapy, tools, T cell therapies solutions, human monoclonal antibodies, magnetic beads applications, stem cells option and nanomedicine. Many of PCR kits are approved for clinical use as they are marked with CE-IVD. Among them, the kits are for influeunza H5N1, Zika virus, human H1N1 of swine origin H1N1, Dengue virus, Yellow fever virus etc. It has largest collections of influenza virus solutions particularly detection of the viruses ranging from H1 to H16 and N1 to N9. It covers many flaviviruses too. It is working on development of therapeutic immunological molecules and next generation sequencing products. Genekam is developing a number of new solutions in nanomedicine too. It is located in Germany and manufactures its products in Germany.
There is no investment information
No recent news or press coverage available for Genekam Biotechnology AG.
We care about your data, and we'd love to use cookies make your experience better.
